Health care stocks inched lower ahead of the opening bell on Friday. The Health Care SPDR (XLV) was down 0.1% while the iShares NASDAQ Biotechnology Index (IBB) was flat.
ARCA biopharma (ABIO) was 12% higher after the data and safety monitoring committee recommended the completion of the ASPEN-COVID-19 phase 2b clinical trial with no alterations on the trial design.